$6.43
-2.3452[-26.73%]
At close: Apr 26
$6.43
0[0.00%]
After Hours: 7:09PM EDT
Avenue Therapeutics
(NASDAQ:ATXI)Avenue Therapeutics Stock (NASDAQ:ATXI), Analyst Ratings, Price Targets, Predictions
Avenue Therapeutics Inc has a consensus price target of $16.38, established from looking at the 2 latest analyst ratings. The last 2 analyst ratings were released from Maxim Group and Aegis Capital on December 11, 2023 and April 3, 2023. With an average price target of $16.38 between Maxim Group and Aegis Capital, there's an implied 154.67% upside for Avenue Therapeutics Inc from these 2 analyst ratings.
Analyst Firms Making Recommendations1
Maxim Group
Aegis Capital
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Avenue Therapeutics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 12/11/2023 | ATXI | Buy Now | Avenue Therapeutics | $6.43 | -88.34% | Maxim Group | Jason McCarthy | → $56.25 | Initiates | → Buy | Get Alert |
| 04/03/2023 | ATXI | Buy Now | Avenue Therapeutics | $6.43 | 397.67% | Aegis Capital | David Bouchey | → $2400 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Avenue Therapeutics (ATXI)?
The latest price target for Avenue Therapeutics (NASDAQ: ATXI) was reported by Maxim Group on December 11, 2023. The analyst firm set a price target for $0.75 expecting ATXI to fall to within 12 months (a possible -88.34% downside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Avenue Therapeutics (ATXI)?
The latest analyst rating for Avenue Therapeutics (NASDAQ: ATXI) was provided by Maxim Group, and Avenue Therapeutics initiated their buy rating.
When was the last upgrade for Avenue Therapeutics (ATXI)?
There is no last upgrade for Avenue Therapeutics.
When was the last downgrade for Avenue Therapeutics (ATXI)?
There is no last downgrade for Avenue Therapeutics.
When is the next analyst rating going to be posted or updated for Avenue Therapeutics (ATXI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Avenue Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Avenue Therapeutics was filed on December 11, 2023 so you should expect the next rating to be made available sometime around December 11, 2024.
Is the Analyst Rating Avenue Therapeutics (ATXI) correct?
While ratings are subjective and will change, the latest Avenue Therapeutics (ATXI) rating was a initiated with a price target of $0.00 to $0.75. The current price Avenue Therapeutics (ATXI) is trading at is $6.43, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.